Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc (ETON) Straddle
ETON straddle scan found 36 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 51.6%.
Read more
Trading a ETON straddle lets you take a pure volatility position on Eton Pharmaceuticals Inc without committing to a direction. Eton Pharmaceuticals Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ETON straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on ETON profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Eton Pharmaceuticals Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ETON straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.
It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the ETON straddle is the cleanest expression of that view. Our scanner prices every ETON straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ETON straddle into a catalyst or short a ETON straddle to harvest decay, the options straddle setups that matter are all in one place.
| Feb 19, 2027 | 90.00 | $36.78 | 155 | 9% | 51.6% | $126.78 | $53.23 | 0 |
| Feb 19, 2027 | 85.00 | $32.38 | 155 | 9% | 51.6% | $117.38 | $52.63 | 0 |
| Feb 19, 2027 | 80.00 | $28.53 | 155 | 9% | 50.9% | $108.53 | $51.48 | 0 |
| Feb 19, 2027 | 75.00 | $25.73 | 155 | 9% | 48.6% | $100.73 | $49.28 | 0 |
| May 21, 2027 | 85.00 | $37.75 | 246 | 9% | 48.5% | $122.75 | $47.25 | 0 |
| Nov 20, 2026 | 75.00 | $21.13 | 64 | 9% | 47.5% | $96.13 | $53.88 | 0 |
| May 21, 2027 | 80.00 | $34.90 | 246 | 9% | 46.4% | $114.90 | $45.10 | 0 |
| Feb 19, 2027 | 70.00 | $23.60 | 155 | 9% | 45.5% | $93.60 | $46.40 | 0 |
| Nov 20, 2026 | 70.00 | $17.73 | 64 | 9% | 45.3% | $87.73 | $52.28 | 0 |
| May 21, 2027 | 75.00 | $32.05 | 246 | 9% | 44.6% | $107.05 | $42.95 | 0 |
As of September 18, 2026
Find the right straddle before volatility moves
Track ETON straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→